IL110933A - Tripeptide antithrombotic ingredients, pharmaceutical preparations containing them and their uses - Google Patents
Tripeptide antithrombotic ingredients, pharmaceutical preparations containing them and their usesInfo
- Publication number
- IL110933A IL110933A IL11093394A IL11093394A IL110933A IL 110933 A IL110933 A IL 110933A IL 11093394 A IL11093394 A IL 11093394A IL 11093394 A IL11093394 A IL 11093394A IL 110933 A IL110933 A IL 110933A
- Authority
- IL
- Israel
- Prior art keywords
- group
- compound
- acid
- amino
- arg
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
- C07K5/0823—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp and Pro-amino acid; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
- C07K5/081—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/121,134 US5430023A (en) | 1990-09-28 | 1993-09-14 | Tripeptide antithrombotic agents |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL110933A0 IL110933A0 (en) | 1994-11-28 |
| IL110933A true IL110933A (en) | 1998-12-27 |
Family
ID=22394776
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL11093394A IL110933A (en) | 1993-09-14 | 1994-09-12 | Tripeptide antithrombotic ingredients, pharmaceutical preparations containing them and their uses |
Country Status (31)
| Country | Link |
|---|---|
| US (1) | US5430023A (cs) |
| EP (1) | EP0643073B1 (cs) |
| JP (1) | JPH07149791A (cs) |
| KR (1) | KR100312388B1 (cs) |
| CN (1) | CN1055698C (cs) |
| AT (1) | ATE160574T1 (cs) |
| AU (1) | AU674773B2 (cs) |
| BR (1) | BR9403542A (cs) |
| CA (1) | CA2131982C (cs) |
| CO (1) | CO4290364A1 (cs) |
| CY (1) | CY2072B1 (cs) |
| CZ (1) | CZ286139B6 (cs) |
| DE (1) | DE69407006T2 (cs) |
| DK (1) | DK0643073T3 (cs) |
| ES (1) | ES2110186T3 (cs) |
| FI (1) | FI944231A (cs) |
| GR (1) | GR3026115T3 (cs) |
| HU (1) | HU220620B1 (cs) |
| IL (1) | IL110933A (cs) |
| MY (1) | MY112879A (cs) |
| NO (1) | NO310240B1 (cs) |
| NZ (1) | NZ264438A (cs) |
| PE (1) | PE43695A1 (cs) |
| PH (1) | PH31655A (cs) |
| PL (1) | PL176448B1 (cs) |
| RU (1) | RU2105010C1 (cs) |
| SI (1) | SI0643073T1 (cs) |
| TW (1) | TW275622B (cs) |
| UA (1) | UA32556C2 (cs) |
| YU (1) | YU54194A (cs) |
| ZA (1) | ZA947015B (cs) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2131367A1 (en) * | 1992-03-04 | 1993-09-16 | Sandor Bajusz | New anticoagulant peptide derivatives and pharmaceutical compositions containing the same as well as a process for the preparation thereof |
| JPH09509943A (ja) * | 1994-03-04 | 1997-10-07 | イーライ・リリー・アンド・カンパニー | 抗血栓剤 |
| US5885967A (en) * | 1994-03-04 | 1999-03-23 | Eli Lilly And Company | Antithrombotic agents |
| US5705487A (en) * | 1994-03-04 | 1998-01-06 | Eli Lilly And Company | Antithrombotic agents |
| US5707966A (en) * | 1994-03-04 | 1998-01-13 | Eli Lilly And Company | Antithrombotic agents |
| CA2143533A1 (en) * | 1994-03-04 | 1995-09-05 | Kenneth D. Kurz | Antithrombotic agents |
| ZA951618B (en) * | 1994-03-04 | 1996-08-27 | Lilly Co Eli | Antithrombotic agents |
| US5726159A (en) * | 1994-03-04 | 1998-03-10 | Eli Lilly And Company | Antithrombotic agents |
| US5602101A (en) * | 1994-03-04 | 1997-02-11 | Eli Lilly And Company | Antithrombotic agents |
| US5691356A (en) * | 1994-03-21 | 1997-11-25 | Bristol-Myers Squibb Company | Disubstituted heterocyclic thrombin inhibitors |
| US5710130A (en) * | 1995-02-27 | 1998-01-20 | Eli Lilly And Company | Antithrombotic agents |
| US5914319A (en) * | 1995-02-27 | 1999-06-22 | Eli Lilly And Company | Antithrombotic agents |
| US6046169A (en) * | 1995-06-07 | 2000-04-04 | Cor Therapeutics, Inc. | Inhibitors of factor XA |
| US6069130A (en) | 1995-06-07 | 2000-05-30 | Cor Therapeutics, Inc. | Ketoheterocyclic inhibitors of factor Xa |
| US5919765A (en) * | 1995-06-07 | 1999-07-06 | Cor Therapeutics, Inc. | Inhibitors of factor XA |
| US6022861A (en) * | 1995-06-07 | 2000-02-08 | Cor Therapeutics, Inc. | Ketoheterocyclic inhibitors of factor Xa |
| US5721214A (en) * | 1995-06-07 | 1998-02-24 | Cor Therapeutics, Inc. | Inhibitors of factor Xa |
| US6245743B1 (en) | 1996-06-05 | 2001-06-12 | Cor Therapeutics, Inc. | Inhibitors of factor Xa |
| JP3539607B2 (ja) * | 1997-02-19 | 2004-07-07 | シャープ株式会社 | 空気調和機の運転制御システム |
| WO1998051684A1 (en) | 1997-05-15 | 1998-11-19 | Eli Lilly And Company | Antithrombotic compound |
| US6903075B1 (en) | 1997-05-29 | 2005-06-07 | Merck & Co., Inc. | Heterocyclic amide compounds as cell adhesion inhibitors |
| WO1999064395A1 (en) * | 1998-06-11 | 1999-12-16 | Merck & Co., Inc. | Heterocyclic amide compounds as cell adhesion inhibitors |
| SE9802973D0 (sv) * | 1998-09-03 | 1998-09-03 | Astra Ab | Immediate release tablet |
| US6172081B1 (en) | 1999-06-24 | 2001-01-09 | Novartis Ag | Tetrahydroisoquinoline 3-carboxamide derivatives |
| AU2003215119B2 (en) * | 2002-02-11 | 2008-11-20 | Gold-T Tech, Inc. | Method for preventing thrombus formation |
| US7205315B2 (en) | 2003-09-27 | 2007-04-17 | Sanofi-Aventis Deutschland Gmbh | Bicyclic imino acid derivatives as inhibitors of matrix metalloproteinases |
| CN102391360B (zh) * | 2011-11-02 | 2013-07-03 | 东南大学 | 一种抗血栓和血小板聚集的小肽 |
| KR102388531B1 (ko) * | 2021-07-07 | 2022-04-21 | 이재호 | 특장차용 스마트 유압 시스템 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU177098B (en) * | 1979-01-04 | 1981-07-28 | Gyogyszerkutato Intezet | Process for producing new peptidyl-n-carboxy-l-arginin-a |
| HU178398B (en) * | 1979-06-12 | 1982-04-28 | Gyogyszerkutato Intezet | Process for producing new agmatine derivatives of activity against haemagglutination |
| HU184368B (en) * | 1981-01-13 | 1984-08-28 | Gyogyszerkutato Intezet | Process for preparing d-phenyl-alanyl-l-propyl-l-arginine-ald ehyde-shulphate |
| HU192646B (en) * | 1984-12-21 | 1987-06-29 | Gyogyszerkutato Intezet | Process for preparing new n-alkyl-peptide aldehydes |
| DE3827415A1 (de) * | 1988-08-12 | 1990-02-15 | Behringwerke Ag | Peptidderivate, verfahren zu ihrer herstellung und ihre verwendung |
| IL99527A (en) * | 1990-09-28 | 1997-08-14 | Lilly Co Eli | Tripeptide antithrombotic agents |
-
1993
- 1993-09-14 US US08/121,134 patent/US5430023A/en not_active Expired - Fee Related
-
1994
- 1994-09-03 PH PH48972A patent/PH31655A/en unknown
- 1994-09-12 EP EP94306667A patent/EP0643073B1/en not_active Expired - Lifetime
- 1994-09-12 DK DK94306667.0T patent/DK0643073T3/da active
- 1994-09-12 ES ES94306667T patent/ES2110186T3/es not_active Expired - Lifetime
- 1994-09-12 TW TW083108392A patent/TW275622B/zh active
- 1994-09-12 PE PE1994250437A patent/PE43695A1/es not_active Application Discontinuation
- 1994-09-12 ZA ZA947015A patent/ZA947015B/xx unknown
- 1994-09-12 DE DE69407006T patent/DE69407006T2/de not_active Expired - Fee Related
- 1994-09-12 CZ CZ19942220A patent/CZ286139B6/cs not_active IP Right Cessation
- 1994-09-12 NZ NZ264438A patent/NZ264438A/en unknown
- 1994-09-12 SI SI9430122T patent/SI0643073T1/xx unknown
- 1994-09-12 MY MYPI94002404A patent/MY112879A/en unknown
- 1994-09-12 CO CO94040971A patent/CO4290364A1/es unknown
- 1994-09-12 IL IL11093394A patent/IL110933A/en not_active IP Right Cessation
- 1994-09-12 PL PL94305009A patent/PL176448B1/pl unknown
- 1994-09-12 AT AT94306667T patent/ATE160574T1/de not_active IP Right Cessation
- 1994-09-12 UA UA94095984A patent/UA32556C2/uk unknown
- 1994-09-13 NO NO19943402A patent/NO310240B1/no unknown
- 1994-09-13 FI FI944231A patent/FI944231A/fi unknown
- 1994-09-13 AU AU72948/94A patent/AU674773B2/en not_active Ceased
- 1994-09-13 YU YU54194A patent/YU54194A/sh unknown
- 1994-09-13 KR KR1019940022961A patent/KR100312388B1/ko not_active IP Right Cessation
- 1994-09-13 CA CA002131982A patent/CA2131982C/en not_active Expired - Fee Related
- 1994-09-13 BR BR9403542A patent/BR9403542A/pt not_active Application Discontinuation
- 1994-09-13 HU HU9402626A patent/HU220620B1/hu not_active IP Right Cessation
- 1994-09-14 RU RU94034734/04A patent/RU2105010C1/ru not_active IP Right Cessation
- 1994-09-14 CN CN94115165A patent/CN1055698C/zh not_active Expired - Fee Related
- 1994-09-14 JP JP6219854A patent/JPH07149791A/ja active Pending
-
1998
- 1998-02-12 GR GR980400287T patent/GR3026115T3/el unknown
- 1998-09-11 CY CY9802072A patent/CY2072B1/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0643073B1 (en) | Tripeptide antithrombotic agents | |
| EP0542525B1 (en) | Antithrombotic agents | |
| EP0479489B1 (en) | Tripeptide antithrombotic agents | |
| EP0670310B1 (en) | Bisulfite adducts of arginine aldehydes useful as thrombin inhibitors and as anticoagulants | |
| RU2142469C1 (ru) | Пептидные производные, их стереоизомеры или физиологически приемлемые соли, обладающие противотромбозной, противосвертывающей или противовоспалительной активностью, способ их получения, фармацевтическая композиция, способ подавления тромбина, способ подавления кининогеназ, применение соединений в качестве исходных в синтезе ингибитора тромбина | |
| US5252566A (en) | Antithrombotic agents | |
| US5416093A (en) | Antithrombotic agents | |
| CZ129694A3 (en) | Novel peptide derivatives | |
| EP0672657B1 (en) | Antithrombotic agents |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| MM9K | Patent not in force due to non-payment of renewal fees |